Type 2 diabetes – Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines
- 1 December 2015
- journal article
- Published by Elsevier in Tuberculosis
- Vol. 95 (6) , 707-712
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- IL-26 Is Overexpressed in Rheumatoid Arthritis and Induces Proinflammatory Cytokine Production and Th17 Cell GenerationPLOS Biology, 2012
- The role of IL-10 in immune regulation during M. tuberculosis infectionMucosal Immunology, 2011
- Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and DiseaseAnnual Review of Immunology, 2011
- State of the union between metabolism and the immune system in type 2 diabetesGenes & Immunity, 2011
- Type 2 diabetes as an inflammatory diseaseNature Reviews Immunology, 2011
- IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseasesExpert Opinion on Therapeutic Targets, 2010
- IL-10 family of cytokinesCytokine & Growth Factor Reviews, 2010
- IL-22 defines a novel immune pathway of antifungal resistanceMucosal Immunology, 2010
- Tuberculosis and diabetes mellitus: convergence of two epidemicsThe Lancet Infectious Diseases, 2009
- Tuberculosis in Poorly Controlled Type 2 Diabetes: Altered Cytokine Expression in Peripheral White Blood CellsClinical Infectious Diseases, 2008